Autonomix Medical Receives European Patent Titled Systems For Assessing Neural Activity In An Eye

Autonomix Medical, Inc. (NASDAQ: AMIX) has been granted European Patent No. EP 4 233 700 B1 for its technology titled 'Systems for Assessing Neural Activity in an Eye.' This patent enhances the company's intellectual property portfolio and provides additional protection for its technologies related to autonomic nervous system assessment and precision neuromodulation in Europe.